BEVERLY, Mass. – President and CEO Kevin Smith says 2025 marked a critical turning point for Inogen, with the company ...
Inogen reported total revenue of $81.7 million for the fourth quarter of 2025, a 2% increase compared to the same period last year, primarily driven by higher growth in international ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a ...
Noted a shift of large customer orders from Q4 2025 into the first half of 2026 due to customer capital and budgeting ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction ...
With a new CEO in place and its revenues on the rebound after a tumultuous 2020, Inogen is looking to make its product line of at-home and portable oxygen concentrators bigger and better than ever.
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results